See All Slides - tctmd.com

Slides

Presentation TCT 2013

TCT-3. Outcomes in STEMI patients treated with clopidogrel or prasugrel: A propensity adjusted analysis from the INFUSE-AMI Trial

Presenter: Keith Oldroyd

October 29, 2013

Presentation TCT 2013

How Did I Treat?

Presenter: Anita Asgar

October 29, 2013

Presentation TCT 2013

Does Revascularization Benefit Patients with Systolic Dysfunction (With or Without Ischemia and/or Viability)

Presenter: Robert Bonow

October 29, 2013

Presentation TCT 2013

The Imaging Revolution Will Forever Change the Approach to Coronary Artery Disease

Presenter: Stephan Achenbach

October 29, 2013

Presentation TCT 2013

TCT-8. 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent:...

Presenter: Byoung Kwon Lee

October 29, 2013

Presentation TCT 2013

How and When Do I Assess a Jailed Side Branch After Provisional Stenting?

Presenter: Bon-Kwon Koo

October 29, 2013

Presentation TCT 2013

Case Presentation and Topic Review: Why Does This Patient Have Outflow Tract Obstruction?

Presenter: Mark Sherrid

October 29, 2013

Presentation TCT 2013

Position Statement: Given the Advances in Stent Technology, Pharmacology, Imaging and Technique, All the Prior PCI vs. CABG Trials Are Archaic and Obsolete!

Presenter: Dean Kereiakes

October 29, 2013

Presentation TCT 2013

Early Vascular Restoration following treatment of single de-novo coronary artery lesions with the DESolve Nx Novolimus Eluting Bioresorbable Coronary Scaffold System (NEBCSS) at 6 months: Insights...

Presenter: J. Ribamar Costa Jr.

October 29, 2013

Presentation TCT 2013

CoreValve US Pivotal Study Design and Extreme Risk Results

Presenter: Steven Yakubov

October 29, 2013

Advertisement

Slides

TCT-3. Outcomes in STEMI patients treated with clopidogrel or prasugrel: A propensity adjusted analysis from the INFUSE-AMI Trial

How Did I Treat?

Does Revascularization Benefit Patients with Systolic Dysfunction (With or Without Ischemia and/or Viability)

The Imaging Revolution Will Forever Change the Approach to Coronary Artery Disease

TCT-8. 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent:...

How and When Do I Assess a Jailed Side Branch After Provisional Stenting?

Case Presentation and Topic Review: Why Does This Patient Have Outflow Tract Obstruction?

Position Statement: Given the Advances in Stent Technology, Pharmacology, Imaging and Technique, All the Prior PCI vs. CABG Trials Are Archaic and Obsolete!

Early Vascular Restoration following treatment of single de-novo coronary artery lesions with the DESolve Nx Novolimus Eluting Bioresorbable Coronary Scaffold System (NEBCSS) at 6 months: Insights...

CoreValve US Pivotal Study Design and Extreme Risk Results

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content